Treatment of posterior circulation stroke: Acute management and secondary prevention.


Journal

International journal of stroke : official journal of the International Stroke Society
ISSN: 1747-4949
Titre abrégé: Int J Stroke
Pays: United States
ID NLM: 101274068

Informations de publication

Date de publication:
08 2022
Historique:
pubmed: 7 6 2022
medline: 9 8 2022
entrez: 6 6 2022
Statut: ppublish

Résumé

One-fifth of strokes occur in the territory of the posterior circulation, but their management, particularly acute reperfusion therapy and neurointervention procedures for secondary prevention, has received much less attention than similar interventions for the anterior circulation. In this review, we overview the treatment of posterior circulation stroke, including both interventions in the acute setting and secondary prevention. We focus on areas in which the management of posterior circulation stroke differs from that of stroke in general and highlight recent advances.Effectiveness of acute revascularization of posterior circulation strokes remains in large parts unproven. Thrombolysis seems to have similar benefits and lower hemorrhage risks than in the anterior circulation. The recent ATTENTION and BAOCHE trials have demonstrated that thrombectomy benefits strokes with basilar artery occlusion, but its effect on other posterior occlusion sites remains uncertain. Ischemic and hemorrhagic space-occupying cerebellar strokes can benefit from decompressive craniectomy.Secondary prevention of posterior circulation strokes includes aggressive treatment of cerebrovascular risk factors with both drugs and lifestyle interventions and short-term dual anti-platelet therapy. Randomized controlled trial (RCT) data suggest basilar artery stenosis is better treated with medical therapy than stenting, which has a high peri-procedural risk. Limited data from RCTs in stenting for vertebral stenosis suggest that intracranial stenosis is currently best treated with medical therapy alone; the situation for extracranial stenosis is less clear where stenting for symptomatic stenosis is an option, particularly for recurrent symptoms; larger RCTs are required in this area.

Identifiants

pubmed: 35658624
doi: 10.1177/17474930221107500
pmc: PMC9358302
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

723-732

Subventions

Organisme : British Heart Foundation
ID : RE/18/1/34212
Pays : United Kingdom

Références

Eur Heart J. 2021 Sep 7;42(34):3227-3337
pubmed: 34458905
Ann Neurol. 2015 Mar;77(3):415-24
pubmed: 25516154
Int J Stroke. 2022 Jul;17(6):694-697
pubmed: 34427475
Lancet Neurol. 2013 Oct;12(10):989-98
pubmed: 24050733
Stroke. 2015 Mar;46(3):746-56
pubmed: 25613308
Lancet Neurol. 2015 Jun;14(6):606-14
pubmed: 25908089
Eur Stroke J. 2021 Jun;6(2):CLXXXVII-CXCI
pubmed: 34414300
Stroke. 2014 Apr;45(4):1222-38
pubmed: 24481970
Neurology. 2012 Apr 3;78(14):1058-63
pubmed: 22442438
Int J Stroke. 2022 Aug;17(7):714-722
pubmed: 34581223
Lancet Neurol. 2020 Feb;19(2):115-122
pubmed: 31831388
Stroke. 2021 Dec;52(12):3989-3997
pubmed: 34455819
Eur J Neurol. 2019 Feb;26(2):299-305
pubmed: 30218610
Stroke. 2011 Aug;42(8):2175-9
pubmed: 21737807
Int J Stroke. 2021 Oct;16(7):792-797
pubmed: 33573525
Lancet Neurol. 2009 Aug;8(8):724-30
pubmed: 19577962
Int J Stroke. 2022 Aug;17(7):815-819
pubmed: 35102797
Stroke. 2013 Mar;44(3):598-604
pubmed: 23386676
Neurology. 2021 Mar 2;96(9):e1272-e1277
pubmed: 33408145
Stroke. 2015 Jul;46(7):2032-60
pubmed: 26022637
Stroke. 2020 Jan;51(1):254-261
pubmed: 31718503
Eur Stroke J. 2020 Dec;5(4):374-383
pubmed: 33598556
Stroke. 2017 Mar;48(3):631-637
pubmed: 28228577
Lancet. 2014 Jan 25;383(9914):333-41
pubmed: 24168957
J Neurointerv Surg. 2019 Dec;11(12):1174-1180
pubmed: 31239331
Int J Stroke. 2022 Apr 20;:17474930221089772
pubmed: 35272563
JAMA Neurol. 2019 Dec 1;76(12):1466-1473
pubmed: 31424481
N Engl J Med. 2021 May 20;384(20):1910-1920
pubmed: 34010530
Int J Stroke. 2022 Jan;17(1):18-29
pubmed: 34986727
Stroke. 2007 May;38(5):1526-30
pubmed: 17395869
Stroke. 2021 Jul;52(7):e364-e467
pubmed: 34024117
Int J Stroke. 2022 Aug;17(7):761-769
pubmed: 34569885
Ann Neurol. 2022 Jan;91(1):23-32
pubmed: 34786756
Int J Stroke. 2022 Jun;17(5):583-589
pubmed: 35018878
JAMA. 2015 Mar 24-31;313(12):1240-8
pubmed: 25803346
JAMA Neurol. 2021 Apr 1;78(4):434-444
pubmed: 33616642
Stroke. 2022 Mar;53(3):749-757
pubmed: 34666507
Int J Stroke. 2022 Jun;17(5):485-486
pubmed: 35634807
Int J Stroke. 2016 Oct;11(7):768-75
pubmed: 27016515
Stroke. 2020 Mar;51(3):876-882
pubmed: 31914885
Eur Stroke J. 2021 Jun;6(2):III
pubmed: 34414304
Stroke. 2011 Aug;42(8):2212-6
pubmed: 21700936
Lancet Neurol. 2019 Jul;18(7):666-673
pubmed: 31130429
Int J Stroke. 2020 Oct;15(8):849-857
pubmed: 32122288
Neurology. 2017 Sep 19;89(12):1229-1236
pubmed: 28835400
J Vasc Surg. 2006 Jun;43(6):1145-54
pubmed: 16765230
Stroke. 2008 Sep;39(9):2485-90
pubmed: 18617663
Neurosurgery. 2013 May;72(5):777-95; discussion 795
pubmed: 23328689
Neurosurgery. 2020 Oct 15;87(5):982-991
pubmed: 32433730
JAMA Neurol. 2020 May 1;77(5):561-573
pubmed: 32080711

Auteurs

Hugh S Markus (HS)

Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.

Patrik Michel (P)

Stroke Center, Neurology Service, Department of Clinical Neurosciences, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH